Last deal

$3.5M

Amount

Series A

Stage

01.05.2017

Date

4

all rounds

$5.5M

Total amount

General

About Company
ReThink Medical is developing a wrist-worn monitoring device to predict and prevent heart failure hospitalizations.

Industry

Sector :

Subsector :

founded date

01.01.2010

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

ReThink Medical is a medical device and digital health company that aims to revolutionize heart failure management. Their innovative wrist-worn monitoring device, CorBand™, utilizes cutting-edge algorithms and artificial intelligence to detect deteriorating conditions weeks in advance, even before symptoms become noticeable. By continuously monitoring physiological data and employing machine learning, their technology enables data-driven therapy, providing ample time for timely treatment, preventing hospitalizations, and improving patients' quality of life. With a focus on compliance, simplicity, and accuracy, ReThink Medical's proactive approach has the potential to save billions in healthcare costs while enhancing patient care.